BG

Welcome to the Brand page for “BG”, which is offered here for Genetic testing for medical purposes, specifically, genomic, epigenomic, proteomic, transcriptomic, and molecular medical testing for cancer and other diagnostic or treatment purposes; providing medical information, providing collected and analyzed medical information in the field of genetics, epigenetics, and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical information, specifically, providing collected and analyzed medical information in the field of genomics, epigenomics, proteomics, transcriptomics for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; providing online computer databases of genomic sequences for health care and medical purposes, for tracking, matching, searching, testing, aggregating, researching, evaluating health status, and diagnosing diseases and gene mutations; providing an online internet website portal featuring medical information, medical, genetic, epigenetic, genomic, proteomic, and transcriptomic information and data in the field of cancer for diagnostic and treatment purposes; providing an online internet website portal featuring medical information, medical, genetic, epigenetic, genomic, proteomic, and transcriptomic information and data for scientific, laboratory, and medical research and development purposes;providing online, non-downloadable software for genetic and epigenetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing online computer databases featuring scientific research information in the field of genomic sequences for use in scientific research, for tracking, matching, searching, testing, aggregating, researching, and evaluating health status, and diagnosing diseases and gene mutations; software as a service (saas) services featuring software for patient treatment protocols and for recommending treatments to patients; providing an online internet website portal featuring medical, genetic, epigenetic, genomic, epigenomic, proteomic, and transcriptomic research information and data in the field of cancer for diagnostic and treatment purposes; providing an online internet website portal featuring medical, genetic, epigenetic, genomic, epigenomic, proteomic, and transcriptomic research information and data for scientific, laboratory, and medical research and development purposes; medical research services; biomedical research services; structural and functional analysis of genomes; scientific research in the field of genomics and epigenomics; medical laboratory services being medical research, in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders; providing temporary use of online, non-downloadable software used for the sequencing and analyses of genomic, epigenomic, proteomic, and transcriptomic data; providing temporary use of online, non-downloadable software used to integrate and create data models; software as a service (saas) services featuring software for analyzing and visualizing genomic, epigenomic, proteomic, and transcriptomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (saas) services featuring software for data management, for electronic storage of data in the field of clinical trials and electronic health records; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, epigenetics, genomics, proteomics, transcriptomics, and biochemistry; providing online, nondownloadable software for use in clinical trial data management and for management of electronic health records; providing online, non-downloadable software for displaying, recording, and analyzing medical data and medical images;.

Its status is currently believed to be active. Its class is unavailable. “BG” is believed to be currently owned by “BOSTONGENE CORPORATION”.